Schizophrenia Update


Here’s an overview on the latest from the Chair of the Scientific Program Committee of APA 2016.


[[{"type":"media","view_mode":"media_crop","fid":"48599","attributes":{"alt":"","class":"media-image media-image-right","height":"127","id":"media_crop_8195583205184","media_crop_h":"0","media_crop_image_style":"-1","media_crop_instance":"5813","media_crop_rotate":"0","media_crop_scale_h":"0","media_crop_scale_w":"0","media_crop_w":"0","media_crop_x":"0","media_crop_y":"0","style":"float: right;","title":" ","typeof":"foaf:Image","width":"111"}}]]What's new in schizophrenia? APA 2016 is a good place to find out.

The conference will offer at least 10 different seminars and lectures on a wide range of issues, from the treatment of cognitive deficits to negative symptoms to post-discharge strategies.

We have invited Dr. Steve Koh, Scientific Program Chair, to touch briefly on some of the key advances. Dr Koh is Clinical Assistant Professor at University of California, San Diego (UCSD), Director for UCSD Community Psychiatry Fellowship, and UCSD Outpatient Faculty in La Jolla, Calif.

© 2024 MJH Life Sciences

All rights reserved.